RxDoctor Payments Data

Angela Bean, PA

Medical · Corvallis, ORNPI 1578507547

Payments from drug & device makers

$1,755in general payments, 2019–2025

Across 91 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$371
  • AbbVie$238
  • Amgen$181
  • Lilly USA, LLC$143
  • GSK$140
  • Novo Nordisk$109
  • plus $575 from 18 others

What the payments were for

  • Food & beverage$1,71097%
  • Education$453%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,755 in reported general payments places this provider in the 80th percentile of 364 medical providers in Oregon.

See all medical providers in Oregon

Medicare billing

Part B allowed, 2024
$21,808
Medicare patients
106
Services billed
344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$18,385
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$11,947
FarxigaDapagliflozin Propanediol12$6,835
Breo ElliptaFluticasone/Vilanterol14$5,628
Estradiol18$1,299
Levothyroxine Sodium90$1,239
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide18$1,006
Olmesartan Medoxomil42$905
Rosuvastatin Calcium65$814
Losartan Potassium57$740
Omeprazole33$705
Lovastatin26$701
Albuterol Sulfate HfaAlbuterol Sulfate25$691
Duloxetine Hcl21$625
Lisinopril56$593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$371$18,38523 claims
GSKTrelegy Ellipta, Breo Ellipta$140$17,57430 claims
AstraZenecaFarxiga$47$6,83512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 364 medical providers in Oregon.

Other medical in Corvallis

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →